Experienced in Pulmonary Edema

Julie Traclet

Hospices Civils De Lyon, 28 Avenue Doyen Lepine, 
Lyon, FR 
Experienced in Pulmonary Edema
Hospices Civils De Lyon, 28 Avenue Doyen Lepine, 
Lyon, FR 
OverviewLocationsClinical Research

Overview

Julie Traclet practices in Lyon, France. Ms. Traclet is rated as an Experienced expert by MediFind in the treatment of Pulmonary Edema. Her top areas of expertise are Pulmonary Arteriovenous Malformation (PAVM), Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Hypertension, and Lung Transplant.

Her clinical research consists of co-authoring 60 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Pulmonary Edema.

Gender
Female

Locations

Hospices Civils De Lyon, 28 Avenue Doyen Lepine, Lyon, 69677, France
Other Locations
Bron, 69500, France
Tours, France
Paris, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Terminated
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Terminated
Publish Date: August 12, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
Cardiac Function and Exercise Capacity in Pulmonary Arterial Hypertension
Cardiac Function and Exercise Capacity in Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: June 25, 2024
Intervention Type: Behavioral
Study Phase: Not Applicable
Bleeding Frequency Under Anticoagulant Treatment in Pulmonary Hypertension : HEMA-HTP Multicentric Study.
Bleeding Frequency Under Anticoagulant Treatment in Pulmonary Hypertension : HEMA-HTP Multicentric Study.
Enrollment Status: Completed
Publish Date: June 04, 2024
Intervention Type: Drug
Interest of Cardiac Output Measurement by Thoracic Bio-reactance for Monitoring of Patients Treated for a Pulmonary Hypertension
Interest of Cardiac Output Measurement by Thoracic Bio-reactance for Monitoring of Patients Treated for a Pulmonary Hypertension
Enrollment Status: Completed
Publish Date: October 13, 2022
Intervention Type: Device
View 4 Less Clinical Trials

60 Total Publications

Interstitial Lung Disease Associated with Anti-Ku Antibodies: A Case Series of 19 Patients.
Interstitial Lung Disease Associated with Anti-Ku Antibodies: A Case Series of 19 Patients.
Journal: Journal of clinical medicine
Published: November 28, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Traclet's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 27 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile